/desautels/taxonomy/term/2338/all en /desautels/channels/news/profound-appoints-desautels-alumna-its-board-directors-266821 <p>In its 2016 financial results press release, Mississauga-based Profound Medical announced the appointment of <strong>Samira Sakhia</strong> (BCom’90, MBA’01) to its Board of Directors. Ms. Sakhia is also a member of the<strong><a href="http://node/3628" target="_blank"> Desautels International Advisory Board</a></strong> and serves as President of Knight Therapeutics. Prior to that, she was CFO of Paladin Labs, which she helped sell to Dublin-based pharma giant, Endo International.</p> Wed, 08 Mar 2017 16:42:23 +0000 thao.nguyen3@mail.mcgill.ca 67226 at /desautels /desautels/channels/news/announcement-knight-therapeutics-cfo-resignation-275569 <p>Knight Therapeutics has announced the resignation of its chief financial officer, as the company’s president and Desautels International Faculty Advisory Board member, <strong>Samira Sakhia</strong> (BCom’90, DPA’94, MBA’01), takes on the additional responsibility of CFO.</p> <p>In doing so, Sakhia will leverage her 14 years of prior experience as CFO for Paladin Labs Inc.</p> <p><a href="https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aGUD-2514337">Read more</a></p> Wed, 11 Oct 2017 15:54:30 +0000 thao.nguyen3@mail.mcgill.ca 67964 at /desautels /desautels/channels/news/samira-sakhia-present-investor-conference-267907 <p>At the <strong>Bloom Burton & Co Healthcare Investor Conference</strong> this May, Knight Therapeutics’ president, <strong>Samira Sakhia</strong> (BCom’90, DPA’94, MBA’01) will be giving the Montreal-based specialty pharmaceutics company’s corporate update.</p> <p>The event takes place at the Sheraton Centre Hotel at 11:30 on May 1. Those who won’t be at the event, but who are still interested in the presentation, can download a copy at the company’s website (<a href="http://gudknight.com" target="_blank">gudknight.com</a>).</p> Thu, 27 Apr 2017 18:16:43 +0000 julie.lapalme@mcgill.ca 67386 at /desautels /desautels/channels/news/supporting-desautels-student-leadership-aspirations-332895 <p>While leading a pharmaceutical company, <strong>Samira Sakhia</strong> (BCom’90, DPA’94, MBA’01) is also volunteering her expertise in the broader ���ϲ����� community and supporting students in realizing their leadership potential through the Samira Sakhia MBA Leadership Award.</p> <p><a class="button--outline" href="/desautels/article/bcom-program-equity-diversity-and-inclusion-mba-stories-supporting-desautels/samira-sakhia-taking-helm-knight-therapeutics-and-supporting-desautels-student-leadership" target="_blank">Learn more</a></p> Mon, 30 Aug 2021 15:17:50 +0000 angela.l.williams@mcgill.ca 81123 at /desautels /desautels/channels/news/desautels-alumna-becomes-president-ceo-knight-therapeutics-inc-331176 <p>Congratulations to <a href="/desautels/samira-sakhia"><strong>Samira Sakhia</strong></a> (BCom’90, DPA’94, MBA’01), who will take on a new challenge as President and Chief Executive Officer of Knight Therapeutics Inc., a Montreal-based company focused on acquiring or in-licensing and commercializing innovative pharmaceutical products for Canada and Latin America. Sakhia brings more than 20 years of leadership experience in the pharmaceutical industry to the role.   </p> Fri, 21 May 2021 17:42:36 +0000 angela.l.williams@mcgill.ca 80824 at /desautels /desautels/article/bcom-program-equity-diversity-and-inclusion-mba-stories-supporting-desautels/samira-sakhia-taking-helm-knight-therapeutics-and-supporting-desautels-student-leadership <p><b><a href="/desautels/samira-sakhia">Samira Sakhia</a>, </b>BCom’90, DPA’94, MBA’01, entered the BCom program as a self-described “numbers person” and naturally gravitated towards earning a Chartered Professional Accountant (CPA) designation after graduation. “The finance calculations and economic courses came easily for me,” says Sakhia, who gained valuable early experience with Arthur Anderson auditing many different types of industries and companies.</p> Tue, 24 Aug 2021 22:38:33 +0000 ���ϲ����� University Advancement 81086 at /desautels /desautels/channels/news/knight-reborn-262316 <p>Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that <strong>Samira Sakhia</strong>, former CFO of Paladin Labs Inc. ("Paladin"), will be joining the Knight team as President and member of the Board of Directors. In her new role, beginning on August 31, 2016, Samira will report to <strong>Jonathan Ross Goodman</strong>, CEO of Knight.</p> Fri, 19 Aug 2016 15:10:35 +0000 thao.nguyen3@mail.mcgill.ca 66422 at /desautels /desautels/channels/news/people-move-october-2016-update-263302 <p><strong>Samira Sakhia</strong>, president of Knight Therapeutics, has joined Crescita Therapeutics Inc.’s board of directors.  Prior to her current role, she was the chief financial officer of Paladin Labs. She holds a Bachelor of Commerce degree in Finance and Accounting and a Masters of Business Administration in Strategy and Marketing from ���ϲ����� University and is a Chartered Professional Accountant. Additionally, Dr. Henrich Guntermann and Klaus von Lindeiner have tendered their resignations as board members of the company.</p> Thu, 06 Oct 2016 15:47:46 +0000 thao.nguyen3@mail.mcgill.ca 66599 at /desautels /desautels/channels/news/nuvo-researchr-announces-appointment-its-board-directors-256500 <p>Nuvo Research Inc. (TSX:NRI) (Nuvo or the Company), a specialty pharmaceutical company with growing revenues and a diverse portfolio of topical and immunology products, today announced the appointment of <strong>Samira Sakhia</strong> to its Board of Directors. </p> <p>Read full article: <a href="http://www.mediawebsite.net/dallassouthnews/story/?catSetID=&catID=290937&nrid=339775632" target="_blank">Dallas South News</a>, November 3, 2015</p> <p> </p> Tue, 03 Nov 2015 15:56:03 +0000 arifa.nitol@mail.mcgill.ca 65218 at /desautels /desautels/channels/news/crescita-therapeutics-announces-changes-board-directors-263171 <p>Crescita Therapeutics Inc. (Crescita or the Company), a commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms, today announced that <strong>Samira Sakhia</strong>, President of Knight Therapeutics, has joined its board of directors. Prior to her current role, Ms. Sakhia was the Chief Financial Officer of Paladin Labs. Ms.</p> Fri, 30 Sep 2016 17:00:54 +0000 thao.nguyen3@mail.mcgill.ca 66575 at /desautels /desautels/channels/news/people-move-augustseptember-2016-262707 <p>A monthly roundup of  ‘people on the move’ in Canada’s life science and biotech sectors.</p> <p>...<strong>Samira Sakhia</strong>, former CFO of Paladin Labs Inc. , has joined the Knight Therapeutics Inc. team as president and as member of the company’s board of directors. Ms. Sakhia served as the CFO at Paladin (acquired by Endo International plc February 2014), from 2001 to 2015. She holds an MBA and a Bachelors of Commerce degree from ���ϲ����� University and is also a Chartered Professional Accountant.</p> Tue, 13 Sep 2016 18:40:31 +0000 thao.nguyen3@mail.mcgill.ca 66504 at /desautels